Regenxbio
RGNX
RGNX
186 hedge funds and large institutions have $458M invested in Regenxbio in 2024 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 66 increasing their positions, 50 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.53% less ownership
Funds ownership: 88.88% → 88.36% (-0.53%)
11% less capital invested
Capital invested by funds: $512M → $458M (-$54.1M)
77% less call options, than puts
Call options by funds: $1.5M | Put options by funds: $6.66M
Holders
186
Holding in Top 10
3
Calls
$1.5M
Puts
$6.66M
Top Buyers
| 1 | +$5.94M | |
| 2 | +$3.41M | |
| 3 | +$3.39M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$3.29M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.62M |
Top Sellers
| 1 | -$7.81M | |
| 2 | -$5.61M | |
| 3 | -$5.32M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$2.92M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$2.69M |